Uncoupling protein-2 (UCP2) is expressed in large amounts in several tissues. In the mouse brain, in situ hybridization studies have revealed an abundant expression of UCP2 mRNA in the ventral septal region, the hypothalamus, the hindbrain (medulla), the ventricular regions and the cerebellum. In the hypothalamus, a very highly intense hybridization signal is apparent in the suprachiasmatic nucleus, in the medial parvicellular and magnocellular lateral parts of the paraventricular hypothalamic nucleus, and in the arcuate nucleus. In the brainstem, UCP2 is found to be strongly expressed in the dorsal motor nucleus of the vagus nerve. The expression of UCP2 mRNA is also clearly noticeable in the choroid plexuses and in the cerebellum. The expression of UCP2 mRNA in speci®c regions of the brain as well as its presence in neurons with a known chemical identity suggest that UCP2 mRNA is expressed in neurons. It is as yet premature to conclude about a speci®c function of UCP2 in the brain. The brain distribution pattern of its transcript suggests that this mitochondrial protein could be part of neuronal circuitries involved in the control of neuroendocrine functions and autonomic responses. Assuming that the UCP2 mRNA encodes a functional uncoupling protein, it can be argued that UCP2 contributes to the metabolic rate and thermoregulation of the neuronal structures to which it is associated. In addition, by elevating oxygen consumption in the brain, UCP2 could in speci®c regions control the production of reactive oxygen species and thereby in¯uence the process of neural degeneration.
Introduction
The uncoupling protein-2 (UCP2) represents one of two newly identi®ed UCPs. In contrast to the genes encoding UCP1 (formerly UCP) and UCP3, the one that encodes UCP2 is expressed in a panoply of tissues including the brain, heart, muscle, liver, intestine, lung, spleen, kidney, testis, uterus, white adipose tissue, and brown adipose tissue 1 ( Figure 1 ). UCP3 is expressed in brown adipose tissue and muscle, 2 whereas UCP1 mRNA in expressed only in brown adipose tissue.
3 UCP2 mRNA is also abundantly expressed in the pituitary, the adrenals (Huang Q and Richard D, unpublished results) and the thymus.
The role of UCP2 has yet to be delineated. From the studies carried out in yeasts, it clearly appears that UCP2 uncouples mitochondrial respiration. 1 However, in contrast to UCP1, whose synthesis and activity are regulated compatibly with its thermogenic function, 4 UCP2 has yet to be conclusively described as a thermogenic protein. The increase in the expression of UCP2 in the muscle following food deprivation 5 is indeed not supportive of a thermogenic function.
The presence of UCP2 mRNA in heterogeneously organized tissues prompted us to conduct a series of studies using in situ hybridization histochemistry to determine the tissue localization of UCP2 mRNA. The overall goal of these studies was to gain insights into a potential role of UCP2. This minireview summarizes some of the ®ndings that emerged from these studies, with focus on the brain sites of expression of UCP 2 mRNA.
Brain expression of UCP2
In the mouse 6 as well as in the rat (Huang, Q et al, unpublished results), UCP2 mRNA is expressed throughout the brain with variable intensity ( Figure  2) . A markedly intense expression is found in the ventral septal region (Figure 2, panel A) , the hypothalamus (Figure 2 , panels B, C, E), the caudal hindbrain (medulla) (Figure 2 , panel F), the ventricular region (Figure 2 panels A±D) , and the cerebellum (Figure 2 panels D). A very highly intense hybridization signal is apparent in the suprachiasmatic nucleus ( Figure 2 , panel B), the parvicellular and magnocellular parts of the paraventricular hypothalamic nucleus ( Figure 2 , panel E), the arcuate nucleus, the dorsal motor nucleus of the vagus nerve ( Figure 2 , panel F), and the choroid plexus ( Figure 2 , panels B±D). In contrast to the rat, the mouse expresses, respectively, low and high levels of UCP2 mRNA in the hippocampus and cerebellum. The reasons for these differences between rat and mouse have yet to be elucidated.
The evidence accumulated so far suggests that the expression of UCP2 in the brain is speci®cally neuronal.
In many regions of the brain, the autoradiography grains revealing UCP2 mRNA agglomerate as if they delineate individual cells. Such agglomerations can be seen in the dorsal motor nucleus of the vagus nerve in Figure 2 , panel F. Also supporting the neuronal localization of UCP2 mRNA are recent ®ndings demonstrating that the corticotrophin-releasing factor-containing neurons of the hypothalamic paraventricular nucleus express UCP2 mRNA. Although the possibility that UCP2 is expressed in glial cells cannot be excluded, there is no evidence to that effect; the general pattern of distribution of UCP2 mRNA is not a priori consonant with a distribution into glial cells. 
Modulation of UCP2 mRNA expression in mouse brain
The factors modulating the expression of UCP2 mRNA in the brain have yet to be determined. None of the stimuli known to in¯uence the expression of UCP1 in brown adipose tissue seems to have marked effects on the expression of UCP2 in the brain (Table  1) . Moreover, a factor such as fasting, which is known to stimulate expression of UCP2 in muscle and white adipose tissue is without apparent (using in situ hybridization histochemistry) effects on expression of UCP2 mRNA in the brain.
Potential functions of UCP2 in the brain
The speci®c function of UCP2 in the brain has not been elucidated. It is unclear whether the UCP2 gene expresses a functional uncoupling protein in the brain. Assuming this is the case, it may be argued that the presence of UCP2 contributes to the high metabolic rate of brain tissue. The presence of UCP2 in the brain could represent a mechanism underlying the proton leaks which could account for up to 25% of the resting O 2 consumption in the brain. 7 The uncoupling of mitochondria could also attenuate the production of reactive oxygen species, as recently suggested. 8 Indeed, mild uncoupling of mitochondria during state 3±state 4 transition (that is when the ADP pool is phosphorylated to ATP) can prevent the one electron reduction of O 2 to the superoxide anion radical (O 2 7 ) and consequently alleviate the production of other harmful free radicals such as hydrogen peroxide (H 2 O 2 ), which could participate in the process of neural degeneration. 9 The pattern of expression of UCP2 mRNA suggests that UCP2 may be part of neuronal circuitries controlling neuroendocrine and autonomic functions, though this hypothesis is not consonant with the apparent lack of regulation in UCP2 brain expression by factors such as food deprivation, leptin, corticosterone and obesity (Table 1) . Nonetheless the expression of UCP2 mRNA in hypophysiotropic neurons of the paraventricular hypothalamic nucleus, which expresses hypophysiotropic peptides such as corticotrophin-releasing hormone and thyrotropin-releasing hormone, is supportive of a role of UCP2 in neuroendocrine functions. In addition, the distribution of UCP2, which is clearly noticeable in structures such as the medial preoptic area, the ventromedial hypothalamic nucleus, the parabrachial nucleus and the motor nuclei of parasympathetic cranial nerves (vagus, hypoglossal, oculomotor and facial nerves), indicates that UCP2 could be closely associated with the control of the sympathetic and parasympathetic nervous system activity.
Conclusion
UCP2 mRNA is expressed throughout the brain with variable intensity. A markedly intense expression is found in several parts of the brain that include the hypothalamus, the thalamus, the brainstem, the cerebellum, and the choroid plexuses. The parenchymal expression appears largely neuronal. The function of UCP2 in the brain has yet to be elucidated. Assuming that the UCP2 gene encodes an uncoupling protein, it can be argued that UCP2 participates in the thermoregulation of the brain as well as in the process of neural degeneration, for instance, through controlling the production of reactive oxygen species. Brain distribution of UCP2 D Richard et al
